During the past decade, UF Health Orlando conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UF Health Orlando" #1 collaborator was "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UF Health Orlando" are "Breast Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "UF Health Orlando" in a lesser frequency.

Most popular intervention types in "UF Health Orlando" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "trastuzumab" (1 trials) and "trastuzumab emtansine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UF Health Orlando" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UF Health Orlando". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UF Health Orlando, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UF Health Orlando, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".